Annual EBIT
-$5.62 M
-$621.90 K-12.45%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual earnings before interest & taxes is -$5.62 million, with the most recent change of -$621.90 thousand (-12.45%) on December 31, 2023.
- During the last 3 years, CPIX annual EBIT has risen by +$689.20 thousand (+10.93%).
- CPIX annual EBIT is now -155.83% below its all-time high of $10.06 million, reached on December 31, 2011.
Performance
CPIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.39 M
-$423.40 K-43.88%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly earnings before interest & taxes is -$1.39 million, with the most recent change of -$423.40 thousand (-43.88%) on September 30, 2024.
- Over the past year, CPIX quarterly EBIT has increased by +$4.71 million (+77.24%).
- CPIX quarterly EBIT is now -137.68% below its all-time high of $3.68 million, reached on June 30, 2011.
Performance
CPIX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$10.22 M
-$442.00 K-4.52%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM earnings before interest & taxes is -$10.22 million, with the most recent change of -$442.00 thousand (-4.52%) on September 30, 2024.
- Over the past year, CPIX TTM EBIT has dropped by -$4.61 million (-82.01%).
- CPIX TTM EBIT is now -196.78% below its all-time high of $10.56 million, reached on September 30, 2011.
Performance
CPIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CPIX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.4% | +77.2% | -82.0% |
| 3 y3 years | +10.9% | +10.8% | -257.7% |
| 5 y5 years | +47.0% | +58.5% | -13.7% |
CPIX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.4% | at low | -230.8% | +77.2% | -853.9% | at low |
| 5 y | 5-year | -12.4% | +37.9% | -230.8% | +77.2% | -853.9% | at low |
| alltime | all time | -155.8% | +47.0% | -137.7% | +77.2% | -196.8% | +11.3% |
Cumberland Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.39 M(+43.9%) | -$10.22 M(+4.5%) |
| Jun 2024 | - | -$964.80 K(-45.6%) | -$9.78 M(+26.1%) |
| Mar 2024 | - | -$1.77 M(-70.9%) | -$7.76 M(+38.1%) |
| Dec 2023 | -$5.62 M(+12.4%) | -$6.10 M(+544.5%) | -$5.62 M(+220.8%) |
| Sep 2023 | - | -$946.20 K(-189.1%) | -$1.75 M(+63.4%) |
| Jun 2023 | - | $1.06 M(+190.4%) | -$1.07 M(-68.0%) |
| Mar 2023 | - | $365.60 K(-116.4%) | -$3.35 M(-32.9%) |
| Dec 2022 | -$5.00 M(-8.6%) | -$2.23 M(+736.0%) | -$5.00 M(-29.7%) |
| Sep 2022 | - | -$267.00 K(-78.1%) | -$7.11 M(-15.3%) |
| Jun 2022 | - | -$1.22 M(-4.4%) | -$8.40 M(+30.8%) |
| Mar 2022 | - | -$1.28 M(-70.6%) | -$6.42 M(+17.5%) |
| Dec 2021 | -$5.46 M(-13.4%) | -$4.35 M(+179.4%) | -$5.46 M(+91.2%) |
| Sep 2021 | - | -$1.56 M(-305.3%) | -$2.86 M(+14.4%) |
| Jun 2021 | - | $758.00 K(-337.7%) | -$2.50 M(-48.0%) |
| Mar 2021 | - | -$318.90 K(-81.7%) | -$4.81 M(-23.7%) |
| Dec 2020 | -$6.31 M(-30.3%) | -$1.74 M(+45.5%) | -$6.31 M(-20.3%) |
| Sep 2020 | - | -$1.20 M(-22.9%) | -$7.91 M(-20.2%) |
| Jun 2020 | - | -$1.55 M(-14.5%) | -$9.91 M(+3.2%) |
| Mar 2020 | - | -$1.82 M(-45.7%) | -$9.60 M(+6.8%) |
| Dec 2019 | -$9.04 M(-14.7%) | -$3.35 M(+4.7%) | -$8.99 M(-22.0%) |
| Sep 2019 | - | -$3.20 M(+157.2%) | -$11.53 M(+15.6%) |
| Jun 2019 | - | -$1.24 M(+2.9%) | -$9.97 M(+5.5%) |
| Mar 2019 | - | -$1.21 M(-79.4%) | -$9.45 M(-10.9%) |
| Dec 2018 | -$10.61 M(+180.5%) | -$5.88 M(+258.3%) | -$10.61 M(+91.1%) |
| Sep 2018 | - | -$1.64 M(+128.1%) | -$5.55 M(+19.3%) |
| Jun 2018 | - | -$719.30 K(-69.6%) | -$4.65 M(-16.1%) |
| Mar 2018 | - | -$2.37 M(+188.7%) | -$5.55 M(+46.7%) |
| Dec 2017 | -$3.78 M(+207.9%) | -$820.80 K(+10.2%) | -$3.78 M(-2.4%) |
| Sep 2017 | - | -$744.50 K(-53.8%) | -$3.87 M(+31.4%) |
| Jun 2017 | - | -$1.61 M(+166.2%) | -$2.95 M(+109.0%) |
| Mar 2017 | - | -$605.30 K(-33.7%) | -$1.41 M(+14.8%) |
| Dec 2016 | -$1.23 M(-193.0%) | -$913.00 K(-602.2%) | -$1.23 M(+907.0%) |
| Sep 2016 | - | $181.80 K(-346.3%) | -$122.00 K(-491.0%) |
| Jun 2016 | - | -$73.80 K(-82.6%) | $31.20 K(-96.3%) |
| Mar 2016 | - | -$423.50 K(-318.9%) | $836.80 K(-36.6%) |
| Dec 2015 | $1.32 M | $193.50 K(-42.2%) | $1.32 M(-37.7%) |
| Sep 2015 | - | $335.00 K(-54.2%) | $2.12 M(-26.4%) |
| Jun 2015 | - | $731.80 K(+1109.6%) | $2.88 M(-15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $60.50 K(-93.9%) | $3.40 M(-10.9%) |
| Dec 2014 | $3.81 M(-206.7%) | $992.70 K(-9.5%) | $3.81 M(+820.1%) |
| Sep 2014 | - | $1.10 M(-11.9%) | $414.10 K(-119.0%) |
| Jun 2014 | - | $1.25 M(+161.9%) | -$2.18 M(-51.8%) |
| Mar 2014 | - | $475.40 K(-119.8%) | -$4.51 M(+26.4%) |
| Dec 2013 | -$3.57 M(-139.1%) | -$2.40 M(+60.8%) | -$3.57 M(-267.3%) |
| Sep 2013 | - | -$1.49 M(+36.9%) | $2.13 M(-68.2%) |
| Jun 2013 | - | -$1.09 M(-177.0%) | $6.72 M(-31.6%) |
| Mar 2013 | - | $1.42 M(-57.0%) | $9.82 M(+7.7%) |
| Dec 2012 | $9.12 M(-9.3%) | $3.30 M(+7.0%) | $9.12 M(+20.1%) |
| Sep 2012 | - | $3.09 M(+53.1%) | $7.60 M(-0.8%) |
| Jun 2012 | - | $2.02 M(+180.7%) | $7.66 M(-17.9%) |
| Mar 2012 | - | $718.30 K(-59.5%) | $9.33 M(-7.3%) |
| Dec 2011 | $10.06 M(+50.1%) | $1.77 M(-43.7%) | $10.06 M(-4.8%) |
| Sep 2011 | - | $3.15 M(-14.5%) | $10.56 M(+6.6%) |
| Jun 2011 | - | $3.68 M(+153.9%) | $9.91 M(+36.0%) |
| Mar 2011 | - | $1.45 M(-36.3%) | $7.28 M(+8.6%) |
| Dec 2010 | $6.70 M(+14.4%) | $2.28 M(-8.6%) | $6.70 M(+30.0%) |
| Sep 2010 | - | $2.49 M(+135.1%) | $5.15 M(+2.1%) |
| Jun 2010 | - | $1.06 M(+21.7%) | $5.05 M(+9.9%) |
| Mar 2010 | - | $871.20 K(+19.2%) | $4.59 M(-21.6%) |
| Dec 2009 | $5.86 M(-22.2%) | $730.80 K(-69.4%) | $5.86 M(-12.3%) |
| Sep 2009 | - | $2.39 M(+294.9%) | $6.68 M(+2.8%) |
| Jun 2009 | - | $604.30 K(-71.7%) | $6.50 M(-16.5%) |
| Mar 2009 | - | $2.13 M(+37.3%) | $7.78 M(+3.4%) |
| Dec 2008 | $7.52 M(+5.8%) | $1.55 M(-29.5%) | $7.52 M(+1.7%) |
| Sep 2008 | - | $2.20 M(+16.7%) | $7.40 M(+0.0%) |
| Jun 2008 | - | $1.89 M(+0.7%) | $7.40 M(-3.2%) |
| Mar 2008 | - | $1.88 M(+31.1%) | $7.64 M(+7.5%) |
| Dec 2007 | $7.11 M(+192.6%) | $1.43 M(-35.0%) | $7.11 M(+6.5%) |
| Sep 2007 | - | $2.20 M(+3.0%) | $6.68 M(+7.3%) |
| Jun 2007 | - | $2.14 M(+59.3%) | $6.22 M(+26.4%) |
| Mar 2007 | - | $1.34 M(+34.2%) | $4.92 M(+102.4%) |
| Dec 2006 | $2.43 M(+191.5%) | $999.10 K(-42.7%) | $2.43 M(+69.8%) |
| Sep 2006 | - | $1.74 M(+108.6%) | $1.43 M(-557.8%) |
| Jun 2006 | - | $835.60 K(-172.8%) | -$312.50 K(-72.8%) |
| Mar 2006 | - | -$1.15 M | -$1.15 M |
| Dec 2005 | $833.50 K | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual EBIT year-on-year change?
- What is Cumberland Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly EBIT year-on-year change?
- What is Cumberland Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM EBIT year-on-year change?
What is Cumberland Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CPIX is -$5.62 M
What is the all time high annual EBIT for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual earnings before interest & taxes is $10.06 M
What is Cumberland Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CPIX annual earnings before interest & taxes has changed by -$621.90 K (-12.45%)
What is Cumberland Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CPIX is -$1.39 M
What is the all time high quarterly EBIT for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly earnings before interest & taxes is $3.68 M
What is Cumberland Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CPIX quarterly earnings before interest & taxes has changed by +$4.71 M (+77.24%)
What is Cumberland Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CPIX is -$10.22 M
What is the all time high TTM EBIT for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM earnings before interest & taxes is $10.56 M
What is Cumberland Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CPIX TTM earnings before interest & taxes has changed by -$4.61 M (-82.01%)